A Retrospective Study of the Natural History of Patients With Severe Perinatal and Infantile Hypophosphatasia (HPP)

Study Identifier:
ENB-011-10
ClinicalTrials.gov Identifier:
NCT01419028
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete

Study Details

Medical Condition
  • Unmapped
Study Drug
    Date
    Aug 2012 - Jun 2013
    Phase 1
    Phase 2
    Phase 3
    Phase 4
    N/A
    Patient Requirements
    Sex: Female & Male
    Age: N/A - N/A
    Requirements Information
    Sex
    Female & Male
    Age
    N/A - N/A

    Study Details

    Medical Condition
    • Unmapped
    Study Drug
      Date
      Aug 2012 - Jun 2013
      Phase 1
      Phase 2
      Phase 3
      Phase 4
      N/A
      Patient Requirements
      Sex: Female & Male
      Age: N/A - N/A years
      Requirements Information

      Protocol Summary

      This study aims to characterize the natural history of patients with severe perinatal or infantile onset HPP.

      Trial Locations

      Location
      Status
      Location
      Cedars-Sinai Medical Center
      Los Angeles, California, United States
      Status
      N/A
      Location
      Indiana University school of medicine
      Indianapolis, Indiana, United States, 46202
      Status
      N/A
      Location
      Shriners Hospital for Children
      Saint Louis, Missouri, United States
      Status
      N/A
      Location
      Oregon Health & Science University
      Portland, Oregon, United States
      Status
      N/A
      Location
      Cook Children's Health Care System
      Fort Worth, Texas, United States
      Status
      N/A
      Location
      Royal Children's Hospital
      Parkville, Australia
      Status
      N/A